⏰ Last chance! Join Premium for $20/month before it increases to $49/month.
US Stocks
ALLO

Allogene Therapeutics, Inc. Common Stock

$1.78
-0.07 (-3.78%)

Volume:

2.307M ($4.11M)
#407 Volume#2275 Dollar Volume

Market Capitalization:

$614.97M
#2893 Market Cap

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Allogene Therapeutics Market Segments

Regular Trading Hours

-0.07(-3.78%)
Open$1.85
Close$1.78
Low$1.76
Low Change-0.09 (-4.86%)
High$1.88
High Change+0.03 (+1.35%)
Range$0.12
Volume2.283M
Dollar Volume$4.06M

Premarket

-0.03(-1.60%)
Open$1.88
Close$1.85
Low$1.85
Low Change-0.03 (-1.60%)
High$1.90
High Change+0.02 (+1.06%)
Range$0.05
Volume24.437K
Dollar Volume$45.21K

Overnight

+0.00(+0.00%)
Open$1.88
Close$1.88
Low$1.88
Low Change0.00 (0.00%)
High$1.88
High Change+0.00 (+0.00%)
Range$0.00
Volume1.852K
Dollar Volume$3.48K

After Hours Yesterday

+0.01(+0.54%)
Open$1.85
Close$1.86
Low$1.85
Low Change0.00 (0.00%)
High$1.88
High Change+0.03 (+1.62%)
Range$0.03
Volume391.924K
Dollar Volume$728.98K

Regular Trading Hours Yesterday

-0.08(-4.15%)
Open$1.93
Close$1.85
Low$1.85
Low Change-0.08 (-4.15%)
High$1.94
High Change+0.01 (+0.51%)
Range$0.09
Volume7.029M
Dollar Volume$13.00M

Premarket Yesterday

-0.02(-1.02%)
Open$1.97
Close$1.95
Low$1.93
Low Change-0.04 (-2.03%)
High$1.97
High Change+0.00 (+0.00%)
Range$0.04
Volume6.895K
Dollar Volume$13.45K

Allogene Therapeutics Top Trades

Allogene Therapeutics's top trade so far today returned +1.35%, while the top short trade returned -7.37%.

Unlock the exact entry and exit times, prices, durations, and more top-performing trades with Finsuba Premium. Learn more >>>

Allogene Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.95
10 Day Moving Average (SMA10)$2.01
20 Day Moving Average (SMA20)$2.04
50 Day Moving Average (SMA50)$1.98
100 Day Moving Average (SMA100)$2.05
200 Day Moving Average (SMA200)$1.97

Allogene Therapeutics Statistics

Average Volume (30 Days)5.58M
P/E Ratio (Current)-4.10
EPS (Current)-$0.48
Dividend Yield0.00%
Free Cash Flow-$102.60M
Cash Ratio1.22
Current Ratio10.72
Quick Ratio10.72
Debt to Equity0.00
Enterprise Value$641.99M
EV to EBITDA-3.81
EV to Sales138.36
Price to Book1.56
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales146.68
Return on Assets-0.30%
Return on Equity-0.38%

Allogene Therapeutics Stock Splits

There have been no stock splits for Allogene Therapeutics (ALLO).

Allogene Therapeutics Dividends

There have been no dividends for Allogene Therapeutics (ALLO).